The European Society of Clinical Microbiology and Infectious Disease (ESCMID) today issued a special excellence award for outstanding achievement to Médecins Sans Frontières (MSF). The award was bestowed in Copenhagen at ESCMID’s annual congress, on behalf of all its members, in light of the charity’s huge contribution to global health over the last 40-years, and in special recognition of…
In European acute care hospitals, on any given day, an estimated 80,000 patients – roughly six percent of all patients – receive antimicrobial treatment to fight a healthcare associated infection (HAI), according to the European Centre for Disease Prevention and Control (ECDC). Report: Walter Depner
A newly launched test enables the quantitative determination of PCT in serum samples, EDTA or lithium heparin plasma samples by latex enhanced immunoturbidimetric methodology. The Stanbio Chemistry Procalcitonin (PCT) LiquiColor Assay was launched by EKF Diagnostics, based in Cardiff, Wales, which explains: ‘Procalcitonin is a marker for bacterial infection and sepsis and has been recognised as…
Dr Ahmed Abd El Wahed, research associate in the Department of Infection Models at the German Primate Centre (DPZ) in Göttingen, has developed a portable laboratory for fast diagnosis of Ebola. The new procedure is six to ten times faster than the one currently used, and equally sensitive. Report: Anja Behringer
The ‘Robert Koch’ plane for medical evacuations (MedEvac) is the winged equivalent of a German hospital isolation ward. Within it, medics with viral haemorrhagic fever while working on the Ebola outbreak in West Africa, receive intensive medical care during any stages of the disease, while being evacuated. Report: Anja Behringer
For the first time, researchers have produced a 3-D image revealing part of the inner structure of an intact, infectious virus, using a unique X-ray laser at the Department of Energy’s SLAC National Accelerator Laboratory. The virus, called Mimivirus, is in a curious class of “giant viruses” discovered just over a decade ago.
At the International Meeting on Emerging Diseases and Surveillance (IMED 2014), in Vienna, this year’s focus was on one particular emerging infectious disease: Ebola. According to the World Health Organisation (WHO), as of January 14th, more than 8.400 people have died of this dangerous disease and more than 21.000 cases were reported in nine countries. Report: Michael Krassnitzer
On 29 July, Dr James Ritchie was attending the American Association of Clinical Chemistry’s annual conference in Chicago when he received the call that a physician and missionary worker, who had been in West Africa, were headed to Atlanta’s Emory University Hospital. Report: Lisa Chamoff
A new extracorporeal nanotech device addresses the root cause of sepsis by removing pathogens and endotoxins simultaneously from blood even before their identification – this genetically engineered mannose-binding lectin protein can also latch on to the Ebola virus... Report: Cynthia E Keen
With an estimated fatality rate of 52%, the need to discover a cure for Ebola has never been more urgent. New research published in Journal of Biomolecular Structure and Dynamics this month suggests that scientists currently investigating potential cures for the Ebola virus should focus more attention on the protein furin.
The Ebola virus disease training modules for health care workers developed in collaboration between experts at Johns Hopkins Medicine and the Centers for Disease Control and Prevention (CDC) are now available.
Earlier this year a drug was launched that can cure hepatitis C without severe side effects in most patients. Whilst the treatment is fast, it is very expensive but does avoid liver cancer and thus makes liver transplants superfluous. This is only one of the many promising developments in hepatitis research that Dr Markus Cornberg of the Medical University Hanover will address at the Medica…
More than 750 British military personnel as well as RFA Argus – the country’s medical ship – have arrived in Sierra Leone, for front line duties in the battle against Ebola. In the meantime Britain tested its readiness for a possible Ebola virus epidemic. Report: Brenda Marsh
Poor logistics logistics and low trained staff numbers are two of the greatest limitations to providing a sufficient molecular diagnostic capacity for Ebola in West Africa, says Andrew S. Thompson, Ph.D., GlobalData’s Senior Analyst.
Fever, vomiting, internal and external bleeding – these are the symptoms of the Ebola virus infection. The current epidemic in Guinea, Liberia and Sierra Leone is the largest recorded Ebola outbreak ever and a serious challenge for the healthcare institutions worldwide.
‘Ebola does not present a direct epidemiological danger for Europe,’ according to Dr Armin Fidler, Lead Advisor on Policy and Strategy at the World Bank, but, he added, ‘Inevitably some Europeans will become infected with Ebola, such as those in the healthcare professions or aid workers.’ Report: Michael Krassnitzer
Unlike some news reports the Ebola virus is not as easily transmitted as influenza or other infections. Still, healthcare and laboratory workers must take precautions to quickly identify those infected and prevent an outbreak. Report: Lisa Chamoff
With strong links with the West Coast of Africa, France is among countries most likely to experience Ebola, with an estimated 20% chance of cases in the homeland before October ends - a few suspected cases have arisen.
Johns Hopkins Medicine has been tasked by the Centers for Disease Control and Prevention to lead a group and to design an interactive Web-based learning program that guides health care workers, nurses and physicians through government-approved protocols to aid clinicians as they provide care to patients who may be at risk of contracting the Ebola virus.
World-renowned experts discussed the situation of predomonant epidemics at the International Roche Infectious Disease Symposium in Barcelona.
The current ebola outbreak in West Africa, which began in December 2013 in Guinea and has since spread to Liberia, Sierra Leone, Nigeria and Congo, is considered the largest ebola outbreak ever in West Africa. As of today more than 2,600 cases were reported and more than 1,400 people have died of the disease.
Frost & Sullivan Life Sciences Senior Research Analyst Sriram Radhakrishnan discusses the available screening options to enable early detection of the virus.
Infants exposed to rodent and pet dander, roach allergens and a wide variety of household bacteria in the first year of life appear less likely to suffer from allergies, wheezing and asthma, according to results of a study conducted by scientists at the Johns Hopkins Children’s Center and other institutions.
The realisation that the fight against C. difficile needs its own specific hygiene management dawned relatively recently. Up to the new millennium a common perception regarding European hospital infection prevention and control was that this bacterium was under control; it was considered a marginal phenomenon, which is why C. difficile was not the focus of problematic pathogen monitoring.
Dutch virologist Ron Fouchier and his colleagues around the world stopped their research into the bird flu virus H5N1 for a whole year to allow an international debate surrounding the benefits and risks of their work.
